Immunoscintigraphy with anti-chromogranin A antibodies in patients with endocrine/neuroendocrine tumors.
Colombo
P
P
Istituto di Scienze Endocrine, Ospedale Maggiore IRCCS, Università di Milano, Italy.
Paganelli
G
G
Magnani
P
P
Songini
C
C
Fazio
F
F
Faglia
G
G
D000236:Adenoma / Q000000981:diagnostic imaging / Q000378:metabolism; D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal; D001921:Brain / Q000000981:diagnostic imaging; D002276:Carcinoid Tumor / Q000150:complications; D002648:Child; D053379:Chromogranin A; D002864:Chromogranins / Q000276:immunology*; D003480:Cushing Syndrome / Q000000981:diagnostic imaging; D004701:Endocrine Gland Neoplasms / Q000000981:diagnostic imaging* / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications; D008297:Male; D008875:Middle Aged; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging* / Q000378:metabolism; D010911:Pituitary Neoplasms / Q000000981:diagnostic imaging / Q000378:metabolism; D016719:Radioimmunodetection
D000911:Antibodies, Monoclonal; D053379:Chromogranin A; D002864:Chromogranins; D000324:Adrenocorticotropic Hormone